CD271 Activation Prevents Low to High-Risk Progression of Cutaneous Squamous Cell Carcinoma and Improves Therapy Outcomes

Spheroids from cutaneous squamous cell carcinoma patients with low-risk or high-risk tumors were established to explore histological features, proliferation, invasion abilities, and molecular pathways modulated in response to CD271 overexpression or activation in vitro.